PT2275441T - Recetores de células t de vih de alta afinidade - Google Patents

Recetores de células t de vih de alta afinidade

Info

Publication number
PT2275441T
PT2275441T PT100086123T PT10008612T PT2275441T PT 2275441 T PT2275441 T PT 2275441T PT 100086123 T PT100086123 T PT 100086123T PT 10008612 T PT10008612 T PT 10008612T PT 2275441 T PT2275441 T PT 2275441T
Authority
PT
Portugal
Prior art keywords
high affinity
cell receptors
affinity hiv
hiv
receptors
Prior art date
Application number
PT100086123T
Other languages
English (en)
Portuguese (pt)
Inventor
Karsten Jakobsen Bent
Eamon Molloy Peter
Li Yi
Mark Dunn Steven
Original Assignee
Immunocore Ltd
Adaptimmune Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0506760A external-priority patent/GB0506760D0/en
Priority claimed from GB0516487A external-priority patent/GB0516487D0/en
Application filed by Immunocore Ltd, Adaptimmune Ltd filed Critical Immunocore Ltd
Publication of PT2275441T publication Critical patent/PT2275441T/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/6425—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the peptide or protein in the drug conjugate being a receptor, e.g. CD4, a cell surface antigen, i.e. not a peptide ligand targeting the antigen, or a cell surface determinant, i.e. a part of the surface of a cell
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/7051—T-cell receptor (TcR)-CD3 complex
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
PT100086123T 2005-04-01 2006-03-29 Recetores de células t de vih de alta afinidade PT2275441T (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0506760A GB0506760D0 (en) 2005-04-01 2005-04-01 High affinity HIV TCRS
GB0516487A GB0516487D0 (en) 2005-08-10 2005-08-10 High affinity HIV T cell receptors

Publications (1)

Publication Number Publication Date
PT2275441T true PT2275441T (pt) 2016-11-18

Family

ID=37053744

Family Applications (1)

Application Number Title Priority Date Filing Date
PT100086123T PT2275441T (pt) 2005-04-01 2006-03-29 Recetores de células t de vih de alta afinidade

Country Status (16)

Country Link
US (2) US8378074B2 (enExample)
EP (4) EP2301964A1 (enExample)
JP (3) JP2008535826A (enExample)
CN (2) CN105461802A (enExample)
AU (1) AU2006228308B2 (enExample)
CA (1) CA2602463C (enExample)
CY (1) CY1118160T1 (enExample)
DK (1) DK2275441T3 (enExample)
ES (2) ES2699320T3 (enExample)
HU (1) HUE032037T2 (enExample)
LT (1) LT2275441T (enExample)
NZ (2) NZ561338A (enExample)
PL (1) PL2275441T3 (enExample)
PT (1) PT2275441T (enExample)
SI (1) SI2275441T1 (enExample)
WO (1) WO2006103429A2 (enExample)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040191260A1 (en) 2003-03-26 2004-09-30 Technion Research & Development Foundation Ltd. Compositions capable of specifically binding particular human antigen presenting molecule/pathogen-derived antigen complexes and uses thereof
AU2003216341A1 (en) 2002-02-20 2003-09-09 Dyax Corporation Mhc-peptide complex binding ligands
WO2006036445A2 (en) 2004-09-24 2006-04-06 Trustees Of Dartmouth College Chimeric nk receptor and methods for treating cancer
WO2008042814A2 (en) * 2006-09-29 2008-04-10 California Institute Of Technology Mart-1 t cell receptors
JP5292550B2 (ja) * 2007-03-23 2013-09-18 静岡県 Ｔ細胞レセプターβ鎖遺伝子及びα鎖遺伝子
WO2009125394A1 (en) * 2008-04-09 2009-10-15 Technion Research & Development Foundation Ltd. Anti human immunodeficiency antibodies and uses thereof
GB0816096D0 (en) * 2008-09-04 2008-10-15 Medigene Ltd Diabetes t cell receptors
ES2625985T3 (es) 2009-03-25 2017-07-21 Altor Bioscience Corporation Receptores de linfocitos T específicos de la vpr del VIH
WO2011044186A1 (en) * 2009-10-06 2011-04-14 The Board Of Trustees Of The University Of Illinois Human single-chain t cell receptors
WO2011059836A2 (en) 2009-10-29 2011-05-19 Trustees Of Dartmouth College T cell receptor-deficient t cell compositions
US9273283B2 (en) 2009-10-29 2016-03-01 The Trustees Of Dartmouth College Method of producing T cell receptor-deficient T cells expressing a chimeric receptor
US12492376B2 (en) 2009-10-29 2025-12-09 The Trustees Of Dartmouth College T-cell receptor-deficient T cell compositions
GB201016672D0 (en) 2010-10-04 2010-11-17 Electronic Shipping Solutions Ltd Secure exchange/authentication of electronic documents
EP2502934B1 (en) 2011-03-24 2018-01-17 Universitätsmedizin der Johannes Gutenberg-Universität Mainz Single chain antigen recognizing constructs (scARCs) stabilized by the introduction of novel disulfide bonds
US9833476B2 (en) 2011-08-31 2017-12-05 The Trustees Of Dartmouth College NKP30 receptor targeted therapeutics
CN104395344B (zh) 2012-05-07 2019-08-13 达特茅斯大学理事会 抗b7-h6抗体、融合蛋白及其使用方法
NZ741124A (en) * 2012-07-27 2019-11-29 Univ Illinois Engineering t-cell receptors
PT3149031T (pt) * 2014-05-29 2020-03-25 Us Health Receptores de células t anti-e7 do papilomavírus humano 16
WO2016014725A1 (en) 2014-07-22 2016-01-28 The University Of Notre Dame Du Lac Molecular constructs and uses thereof
NL2014935B1 (en) 2015-06-08 2017-02-03 Applied Immune Tech Ltd T cell receptor like antibodies having fine specificity.
GB201516272D0 (en) * 2015-09-15 2015-10-28 Adaptimmune Ltd And Immunocore Ltd TCR Libraries
GB201516277D0 (en) 2015-09-15 2015-10-28 Adaptimmune Ltd And Immunocore Ltd TCR libraries
EP3211003A1 (en) * 2016-02-24 2017-08-30 Institut Pasteur T cell receptors from the hiv-specific repertoire, means for their production and therapeutic uses thereof
GB201604953D0 (en) * 2016-03-23 2016-05-04 Immunocore Ltd T cell receptors
IL308831A (en) 2016-04-08 2024-01-01 Immunocore Ltd T cell receptors
DE102017115966A1 (de) * 2017-07-14 2019-01-17 Immatics Biotechnologies Gmbh Polypeptidmolekül mit verbesserter zweifacher Spezifität
US20190016802A1 (en) 2017-07-14 2019-01-17 Immatics Biotechnologies Gmbh Dual specificity polypeptide molecule
WO2019217837A1 (en) * 2018-05-11 2019-11-14 Memorial Sloan-Kettering Cancer Center T cell receptors targeting pik3ca mutations and uses thereof
US12606816B2 (en) * 2018-07-31 2026-04-21 Janux Therapeutics, Inc. Inhibitory T cell receptor peptides and discovery methods
US12234473B2 (en) 2020-12-31 2025-02-25 Immatics US, Inc. CD8 polypeptides, compositions, and methods of using thereof
JP2025508738A (ja) * 2022-02-20 2025-04-10 イムノコア リミテッド Ｈｉｖ特異的結合分子及びｔｃｒ
US12103971B2 (en) 2022-02-20 2024-10-01 Immunocore Limited HIV specific binding molecules
WO2024038165A1 (en) 2022-08-18 2024-02-22 Immunocore Ltd T cell receptor fusion proteins specific for mage a4

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6759243B2 (en) * 1998-01-20 2004-07-06 Board Of Trustees Of The University Of Illinois High affinity TCR proteins and methods
NZ507886A (en) * 1998-05-19 2003-05-30 Avidex Ltd Multivalent T cell receptor complexes
PT1421115E (pt) * 2001-08-31 2005-07-29 Avidex Ltd Receptor de celulas t soluvel
US7751825B2 (en) 2002-06-27 2010-07-06 Qualcomm Incorporated Controlling geographic location information of devices operating in wireless communication systems
AU2003271904B2 (en) 2002-10-09 2009-03-05 Adaptimmune Limited Single chain recombinant T cell receptors
EP2048159B1 (en) 2002-11-09 2014-01-01 Immunocore Ltd. T cell receptor display
NZ550815A (en) * 2004-05-19 2009-04-30 Immunocore Ltd Method of improving T cell receptors

Also Published As

Publication number Publication date
CN105461802A (zh) 2016-04-06
EP2275441B8 (en) 2016-10-19
US9255135B2 (en) 2016-02-09
JP5612623B2 (ja) 2014-10-22
CY1118160T1 (el) 2017-06-28
JP2014205671A (ja) 2014-10-30
ES2699320T3 (es) 2019-02-08
HUE032037T2 (en) 2017-08-28
CN103059128B (zh) 2016-01-20
SI2275441T1 (sl) 2016-11-30
ES2599010T3 (es) 2017-01-31
JP2012144543A (ja) 2012-08-02
EP2985291B1 (en) 2018-09-19
CA2602463C (en) 2018-09-04
EP2985291A1 (en) 2016-02-17
DK2275441T3 (en) 2016-12-12
US20130295063A1 (en) 2013-11-07
PL2275441T3 (pl) 2017-07-31
WO2006103429A2 (en) 2006-10-05
AU2006228308B2 (en) 2012-05-17
NZ584523A (en) 2010-11-26
NZ561338A (en) 2010-04-30
EP2275441A1 (en) 2011-01-19
WO2006103429A3 (en) 2007-03-15
EP2275441B1 (en) 2016-08-24
JP2008535826A (ja) 2008-09-04
US20090214551A1 (en) 2009-08-27
CA2602463A1 (en) 2006-10-05
JP5885220B2 (ja) 2016-03-15
US8378074B2 (en) 2013-02-19
EP2275441A9 (en) 2011-09-14
LT2275441T (lt) 2016-12-12
EP2301964A1 (en) 2011-03-30
EP1863842A2 (en) 2007-12-12
AU2006228308A1 (en) 2006-10-05
CN103059128A (zh) 2013-04-24

Similar Documents

Publication Publication Date Title
PL2275441T3 (pl) Receptory komórek T o wysokim powinowactwie dla HIV
ZA200710009B (en) High affinity melan-AT cell receptors
GB2423490B (en) Separator
GB2424118B (en) Fuel cells
ZA200708037B (en) High affinity HIV T cell receptors
ZAA200501758S (en) Handset
GB0714133D0 (en) Invoice hnancing
GB0600575D0 (en) Electrode
EP1953858A4 (en) FUEL CELL
EP1976047A4 (en) FUEL CELL
EP1970988A4 (en) FUEL CELL
GB0503918D0 (en) Cell
EP1897159A4 (en) LEAD-ALKALI BATTERY
EP1923943A4 (en) COMPONENT FOR CONSTITUTING A FUEL CELL
IL187217A0 (en) Cell nucleus-entering compositions
GB0516487D0 (en) High affinity HIV T cell receptors
GB0516079D0 (en) Separator
GB2445900B (en) Mobile structure for adapting surfaces
GB0500073D0 (en) Electrochemical electrode
GB0522564D0 (en) Cells
GB0411772D0 (en) High affinity telomerase t cell receptors
GB0419644D0 (en) High affinity telomerase t cell receptors
GB0526629D0 (en) Conference folder lapdesk
GB0419643D0 (en) High affinity ny-eso t cell receptors
GB0510475D0 (en) Electrode